Sabinsa and Eurofins enter into global ID testing agreement for proprietary ingredient

Sami-Sabinsa Group

"The vision of a research scientist and a passionate entrepreneur takes on social and commercial expressions." This, in short, explains the genesis and growth of Sami-Sabinsa Group.

Sami-Sabinsa Group is a research-focused multinational health science company that was founded in 1991 by the late Dr. Muhammed Majeed, an internationally renowned scientist and entrepreneur in the field of evidence-based medicine. The company is a leading manufacturer of nutraceuticals and cosmeceutical ingredients, standardized herbal extracts, enzymes, probiotics, nutricosmetics, nutritional fine chemicals, and specialty chemicals.
Read More...

Sabinsa Corporation has elected the analytical testing services company Eurofins Scientific, an international leader in analytical testing with specialties in probiotic and supplement raw material analysis, as their global partner for botanical raw material ID testing as well as testing on Sabinsa’s patented extracts and probiotic ingredients.

Identity testing of proprietary ingredients can get complicated when the testing lab does not know which test methods are best for a specific ingredient. When a testing lab uses different methods than the manufacturer, or even other labs, it can cause inaccurately “failed” test results. This wastes time, money, and sometimes even good will. In response to these market and contract manufacturer challenges in ingredient verification, Eurofins will adopt proprietary methods from Sabinsa to test the company’s ingredients.

“As you look at the supply chain, the need for 3rd party verification is increasing – but it becomes increasingly difficult analytically as new products come to market and test methods are not expanded in validation,” said Anurag Pande, VP Scientific Affairs, Sabinsa. “We believe it will simplify ID testing for our customers to have a lab available with this level of knowledge on testing our proprietary ingredients.”

Proprietary methods developed by Sabinsa’s parent company Sami Labs being shared with Eurofins includes LactoSpore^® enumeration along with extracts such as Curcumin C3 Complex^®, BioPerine^®, ForsLean^® and many more, to support contract manufacturers and marketing companies looking for validation.

Sabinsa Corporation with its state of art analytical lab in India has developed several in-house analytical methods for assay of active components in herbal products. These methods have been validated using ICH guidelines for all major parameters including specificity, precision and accuracy.

About Eurofins – a global leader in bio-analysis

Eurofins Scientific through its subsidiaries believes it is the world leader in food, environment and pharmaceutical products testing services for agroscience, genomics, R&D and for supporting clinical studies. With over 30,000 staff in 400 laboratories across 42 countries, Eurofins offers a portfolio of over 150,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostics. As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.

What We Do

Sami-Sabinsa Group Limited (formerly Sami Labs Limited), a pioneer and global leader in health science, is a leading producer of nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals, probiotics, and enzymes.

The company’s corporate R&D encompasses independent research divisions, including Natural Drugs, Phytochemistry, Synthetic Chemistry, Tissue Culture, Biotechnology, Analytical R&D, Biological Research, Microbiology, and Formulation R&D. These divisions collaborate in a synergistic work model to produce products that adhere to international standards.

With the collective wisdom of over 120 research scientists, Sami-Sabinsa Group has developed standardized natural extracts that render alternative therapy to emerging nutritional and health requirements across the globe.